Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000100·Akero Therapeutics, Inc.
Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Common Stock · CUSIP: 00973Y108
Event date: 2024-12-31
- Filing-level shares
- 6,034,239
- Percent of class
- 8.7%
- JANUS HENDERSON GROUP PLC
Shares: 6,034,239 · Class: 8.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000100
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership